Study questions whether treatment is necessary for mild thyroid problems

Researchers at the University of Pennsylvania School of Medicine have found that leaving a mildly underactive thyroid gland (subclinical hypothyroidism) untreated does not lead to increased cardiovascular risk.

The study results published in the Journal of the American Medical Association, may lead to changes in the clinical treatment of this commonly diagnosed ailment.

The thyroid gland, located at the base of the neck, produces thyroid hormone, which acts throughout the body to regulate metabolism. Patients with underactivity of the thyroid gland, or hypothyroidism, may suffer from a variety of symptoms affecting the functions of the body. These patients are typically treated with medication to increase the thyroid hormone in the body. Likewise, patients with overactivity of the thyroid gland, or hyperthyroidism, may also be symptomatic and require treatment to lower their thyroid hormone levels.

In general, mild thyroid problems are common and often the symptoms can be subtle. It's still unclear exactly who needs to be checked for it and what the risks and benefits of treatment are. Researchers aren't sure whether treating a patient with a mild thyroid problem actually helps them.

"Previous studies have suggested that abnormal levels of thyroid stimulating hormone may represent a cardiac risk factor, the way that increased cholesterol or smoking are risk factors for heart disease." said lead author Anne Cappola, MD, ScM, Assistant Professor of Medicine and Epidemiology. "We set out to answer the question of whether there are cardiovascular consequences resulting from mild thyroid problems."

In this study, Cappola measured thyroid function through a blood test in 3200 men and women, aged 65 and older. These were people who had no reason to have an abnormal test and were not taking thyroid hormone replacement. She categorized them into different groups based on their thyroid blood tests and followed them for 13 years. Cappola found that 1.5% of the group who had a mildly overactive thyroid (subclinical hyperthyroidism) had an increased risk of developing an abnormal heart rhythm, atrial fibrillation, but no other cardiovascular threats such as heart attacks or death. Those with a mildly underactive thyroid gland made up 15 percent of the study, and showed no elevation in their risk of suffering a heart attack, stroke, or death.

Cappola adds, "It's our wish to figure out what is a normal number versus an abnormal number which thyroid level is associated with the highest level of function. Many patients with mild thyroid problems are being treated now and it's not clear if it's actually helping them. We need to put together a bigger picture for the risks and benefits of treatment for mild thyroid abnormalities."

So should general practitioners be screening patients over a certain age every so often for thyroid dysfunction? Some organizations recommend it. "We say there's no evidence, based on our data, that screening would benefit the population. But if you do find someone over the age of 65 with a mildly overactive thyroid, they should be treated," explains Cappola. "There's no evidence you should treat someone with a mildly underactive thyroid in order to help deter cardiovascular disease."

The results of this study will be published in the March 1st, 2006 issue of "JAMA." You can access the journal on-line at: http://jama.ama-assn.org/. The article is titled, "Thyroid Status, Cardiovascular Risk and Mortality, in Older Adults."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds bone density loss associated with levothyroxine